Literature DB >> 28130283

Indian erythrodermic postkala-azar dermal leishmaniasis.

Gomathy Sethuraman1, Neetu Bhari1, Poonam Salotra2, Venkatesh Ramesh3.   

Abstract

Postkala-azar dermal leishmaniasis (PKDL) is a complication of kala-azar or visceral leishmaniasis and is caused by Leishmania donovani. We describe an Indian male patient with the rarer erythrodermic form of PKDL and multiple unusual skin lesions viz. verrucous, annular and mucosal ulceration. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28130283      PMCID: PMC5278336          DOI: 10.1136/bcr-2016-217926

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).

Authors:  A M Musa; E A G Khalil; F A Mahgoub; S Hamad; A M Y Elkadaru; A M El Hassan
Journal:  Ann Trop Med Parasitol       Date:  2005-09

2.  Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis.

Authors:  V Ramesh; G K Katara; S Verma; P Salotra
Journal:  Br J Dermatol       Date:  2011-08       Impact factor: 9.302

3.  Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?

Authors:  Vibhu Mendiratta; Ram Chander
Journal:  Int J Dermatol       Date:  2009-09       Impact factor: 2.736

Review 4.  Short communication: post-kala-azar dermal leishmaniasis--an appraisal.

Authors:  V Ramesh; Ruchi Singh; Poonam Salotra
Journal:  Trop Med Int Health       Date:  2007-07       Impact factor: 2.622

5.  Indian mucosal leishmaniasis due to Leishmania donovani infection.

Authors:  Gomathy Sethuraman; Vinod K Sharma; Poonam Salotra
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

Review 6.  Post-kala-azar dermal leishmaniasis.

Authors:  E E Zijlstra; A M Musa; E A G Khalil; I M el-Hassan; A M el-Hassan
Journal:  Lancet Infect Dis       Date:  2003-02       Impact factor: 25.071

7.  Further Clinical Observations on Post-Kala-Azar Dermal Leishmaniasis.

Authors:  L Everard Napier; C R Das Gupta
Journal:  Ind Med Gaz       Date:  1934-03

8.  Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

Authors:  V Ramesh; Himanshu Kaushal; Ashwani Kumar Mishra; Ruchi Singh; Poonam Salotra
Journal:  BMC Public Health       Date:  2015-10-26       Impact factor: 3.295

  8 in total
  3 in total

1.  Lupus miliaris disseminatus faciei: a distinctive facial granulomatous eruption.

Authors:  Tanvi Dev; Tarkik Thami; Moanaro Longchar; Gomathy Sethuraman
Journal:  BMJ Case Rep       Date:  2017-07-14

Review 2.  Biomarkers in Post-kala-azar Dermal Leishmaniasis.

Authors:  Eduard E Zijlstra
Journal:  Front Cell Infect Microbiol       Date:  2019-07-31       Impact factor: 5.293

3.  An Unusual Presentation of Post kala-azar Dermal Leishmaniasis.

Authors:  Sucheta Pathania; Pramila Kumari; Swastika Suvirya; Jaya Chakravarty
Journal:  Indian Dermatol Online J       Date:  2020-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.